Control Bionics secures deal with Tobii Dynavox, global leader with augmentative and alternative communication solutions Tobii Dynavox will evaluate Control Bionics’ (ASX:CBL) NeuroNode for a ...
With a background in investment banking, Control Bionics CEO Jeremy Steele appreciates the commercial realities of gaining a foothold in the US medical device market. That is: it’s not easy. Initially ...
Control Bionics Limited is a medical device company assisting patients whose ability to communicate verbally or via text and social media is compromised by illnesses, such as Motor Neurone Disease and ...
That is: it’s not easy. Initially, the company took a direct-to-retail, do-it-yourself (DIY) approach with its assistive communication tool, Neuronode. Based on surface electro-myography (EMG), ...